Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 May 15;99(10):2462–2469. doi: 10.1172/JCI119430

Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs adult pituitary function. A model for human pituitary Rathke's cysts.

S Akita 1, C Readhead 1, L Stefaneanu 1, J Fine 1, A Tampanaru-Sarmesiu 1, K Kovacs 1, S Melmed 1
PMCID: PMC508087  PMID: 9153290

Abstract

Leukemia inhibitory factor (LIF) and LIF receptors are expressed in adenohypophyseal cells and LIF regulates pituitary hormone transcription and cell replication in vitro. Therefore, transgenic mice expressing pituitary-directed LIF driven by the rat growth hormone (GH) promoter were generated to evaluate the impact of LIF on pituitary development. Three founders were established with diminished linear growth and body weight (57-65% of wild type [WT]), and intense anterior pituitary LIF immunoreactivity. Cystic cavities observed in pituitary anterior lobes were lined by cuboidal, ciliated epithelial cells, focally immunopositive for cytokeratin and S-100 protein and immunonegative for adenohypophyseal hormones. Transgenic pituitaries showed decreased GH (40%) and prolactin (PRL) (26%) cells, and decreased GH and PRL mRNAs by in situ hybridization. ACTH cells increased 2.2-fold, whereas gonadotrophs and thyrotrophs were unchanged. Serum GH was undetectable (< 0.78 ng/ml), PRL levels were one third of WT (P < 0.05), IGF-I levels were 30% of WT (P < 0. 001), and T4 was normal. 10 human pituitary Rathke's cysts studied all showed conclusive LIF immunoreactivity in cyst-lining cells. Thus, intrapituitary murine LIF overexpression causes cystic invaginations from the anterior wall of Rathke's cleft, suggesting failed differentiation of Rathke's epithelium to hormone-secreting cells. Arrested murine pituitary maturation with formation of pituitary Rathke's cleft cysts, GH deficiency, and short stature provide a model to study human Rathke's cyst pathogenesis.

Full Text

The Full Text of this article is available as a PDF (1,018.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akita S., Malkin J., Melmed S. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. Endocrinology. 1996 Jul;137(7):3140–3143. doi: 10.1210/endo.137.7.8770940. [DOI] [PubMed] [Google Scholar]
  2. Akita S., Webster J., Ren S. G., Takino H., Said J., Zand O., Melmed S. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest. 1995 Mar;95(3):1288–1298. doi: 10.1172/JCI117779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bamber B. A., Masters B. A., Hoyle G. W., Brinster R. L., Palmiter R. D. Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7839–7843. doi: 10.1073/pnas.91.17.7839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Behringer R. R., Mathews L. S., Palmiter R. D., Brinster R. L. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev. 1988 Apr;2(4):453–461. doi: 10.1101/gad.2.4.453. [DOI] [PubMed] [Google Scholar]
  5. Bertherat J., Chanson P., Montminy M. The cyclic adenosine 3',5'-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol Endocrinol. 1995 Jul;9(7):777–783. doi: 10.1210/mend.9.7.7476961. [DOI] [PubMed] [Google Scholar]
  6. Block M. I., Berg M., McNamara M. J., Norton J. A., Fraker D. L., Alexander H. R. Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J Exp Med. 1993 Sep 1;178(3):1085–1090. doi: 10.1084/jem.178.3.1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Borrelli E., Heyman R. A., Arias C., Sawchenko P. E., Evans R. M. Transgenic mice with inducible dwarfism. Nature. 1989 Jun 15;339(6225):538–541. doi: 10.1038/339538a0. [DOI] [PubMed] [Google Scholar]
  8. Gearing D. P., King J. A., Gough N. M. Complete sequence of murine myeloid leukaemia inhibitory factor (LIF). Nucleic Acids Res. 1988 Oct 25;16(20):9857–9857. doi: 10.1093/nar/16.20.9857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hermesz E., Mackem S., Mahon K. A. Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development. 1996 Jan;122(1):41–52. doi: 10.1242/dev.122.1.41. [DOI] [PubMed] [Google Scholar]
  10. Ikeda H., Suzuki J., Sasano N., Niizuma H. The development and morphogenesis of the human pituitary gland. Anat Embryol (Berl) 1988;178(4):327–336. doi: 10.1007/BF00698663. [DOI] [PubMed] [Google Scholar]
  11. Ikeda H., Yoshimoto T. Developmental changes in proliferative activity of cells of the murine Rathke's pouch. Cell Tissue Res. 1991 Jan;263(1):41–47. doi: 10.1007/BF00318398. [DOI] [PubMed] [Google Scholar]
  12. Lloyd R. V., Jin L., Chandler W. F., Horvath E., Stefaneanu L., Kovacs K. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues. Lab Invest. 1993 Nov;69(5):570–575. [PubMed] [Google Scholar]
  13. Metcalf D., Gearing D. P. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5948–5952. doi: 10.1073/pnas.86.15.5948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Miller W. L., Eberhardt N. L. Structure and evolution of the growth hormone gene family. Endocr Rev. 1983 Spring;4(2):97–130. doi: 10.1210/edrv-4-2-97. [DOI] [PubMed] [Google Scholar]
  15. Mindermann T., Wilson C. B. Pediatric pituitary adenomas. Neurosurgery. 1995 Feb;36(2):259–269. doi: 10.1227/00006123-199502000-00004. [DOI] [PubMed] [Google Scholar]
  16. Patterson P. H. Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7833–7835. doi: 10.1073/pnas.91.17.7833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ray D. W., Ren S. G., Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest. 1996 Apr 15;97(8):1852–1859. doi: 10.1172/JCI118615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ross D. A., Norman D., Wilson C. B. Radiologic characteristics and results of surgical management of Rathke's cysts in 43 patients. Neurosurgery. 1992 Feb;30(2):173–179. doi: 10.1227/00006123-199202000-00004. [DOI] [PubMed] [Google Scholar]
  19. Scheithauer B. W. Pathology of the pituitary and sellar region: exclusive of pituitary adenoma. Pathol Annu. 1985;20(Pt 1):67–155. [PubMed] [Google Scholar]
  20. Shen M. M., Leder P. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8240–8244. doi: 10.1073/pnas.89.17.8240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shen M. M., Skoda R. C., Cardiff R. D., Campos-Torres J., Leder P., Ornitz D. M. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J. 1994 Mar 15;13(6):1375–1385. doi: 10.1002/j.1460-2075.1994.tb06391.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Simmons D. M., Voss J. W., Ingraham H. A., Holloway J. M., Broide R. S., Rosenfeld M. G., Swanson L. W. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev. 1990 May;4(5):695–711. doi: 10.1101/gad.4.5.695. [DOI] [PubMed] [Google Scholar]
  23. Stefana B., Ray D. W., Melmed S. Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12502–12506. doi: 10.1073/pnas.93.22.12502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stewart C. L., Kaspar P., Brunet L. J., Bhatt H., Gadi I., Köntgen F., Abbondanzo S. J. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 1992 Sep 3;359(6390):76–79. doi: 10.1038/359076a0. [DOI] [PubMed] [Google Scholar]
  25. Struthers R. S., Vale W. W., Arias C., Sawchenko P. E., Montminy M. R. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature. 1991 Apr 18;350(6319):622–624. doi: 10.1038/350622a0. [DOI] [PubMed] [Google Scholar]
  26. Voss J. W., Rosenfeld M. G. Anterior pituitary development: short tales from dwarf mice. Cell. 1992 Aug 21;70(4):527–530. doi: 10.1016/0092-8674(92)90422-9. [DOI] [PubMed] [Google Scholar]
  27. Wang Z., Ren S. G., Melmed S. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology. 1996 Jul;137(7):2947–2953. doi: 10.1210/endo.137.7.8770918. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES